§ 10. Mr. Millanasked the Minister of Health what action he is taking to obtain fuller information about production costs, profits margins and sales promotion costs of pharmaceutical manu- 538 facturers in the light of the Third Report from the Committee of Public Accounts.
§ Mr. PowellThe industry has been asked for further information on sales promotion costs, and inquiries into costs and profits of a number of firms are being made under the revised voluntary price regulation scheme.
§ Mr. MillanI thank the Minister for this further action. He is aware that there is still considerable public concern. Will he, in particular, look at the recommendations of the Committee of Public Accounts that he should require more information about the costs and accounts of the British subsidiaries of American firms, particularly these adjustments that previously have been made on unverified information?
§ Mr. PowellOf course I have studied the Committee's recommendation. I think that the most useful line of exploration is in the negotiations under the voluntary price regulation scheme.